Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (31-40 of 241) with videos related to

Pageof 25
Sort By:
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib eraNitin Jain, Koen van Besien
Leukemia & Lymphoma|January 30, 2014
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphomaSatyajit Kosuri, Koen van Besien
Cells|November 8, 2024
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role?Michael Daunov, Koen van Besien
The New England Journal of Medicine|March 12, 2010
Stem-cell transplantation for sickle cell diseaseAlexander Dew, Koen van Besien
Leukemia & Lymphoma|June 27, 2019
Donor graft genotypes versus leukemiaHannah K Choe, Koen van Besien
JAMA|April 15, 2010
The next frontier for stem cell transplantation: finding a donor for allLucy A Godley, Koen van Besien
Leukemia & Lymphoma|July 4, 2018
A renaissance for autologous transplantation in follicular lymphoma?Ok-Kyong Chaekal, Koen van Besien
Cytotherapy|March 21, 2015
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cellsCaroline A Lindemans, Koen van Besien
Leukemia & Lymphoma|September 14, 2020
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?Ok-Kyong Chaekal, Koen van Besien
Leukemia & Lymphoma|November 25, 2021
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!Alexandra Gomez-Arteaga, Koen van Besien
Pageof 25

Showing results (31-40 of 241) with videos related to

Sort By:
Pageof 25
Hematology/Oncology Clinics of North America|November 8, 2011
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib eraNitin Jain, Koen van Besien
Leukemia & Lymphoma|January 30, 2014
Great expectations? Conditioning with busulfan, melphalan and thiotepa in recurrent Hodgkin lymphomaSatyajit Kosuri, Koen van Besien
Cells|November 8, 2024
High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role?Michael Daunov, Koen van Besien
The New England Journal of Medicine|March 12, 2010
Stem-cell transplantation for sickle cell diseaseAlexander Dew, Koen van Besien
Leukemia & Lymphoma|June 27, 2019
Donor graft genotypes versus leukemiaHannah K Choe, Koen van Besien
JAMA|April 15, 2010
The next frontier for stem cell transplantation: finding a donor for allLucy A Godley, Koen van Besien
Leukemia & Lymphoma|July 4, 2018
A renaissance for autologous transplantation in follicular lymphoma?Ok-Kyong Chaekal, Koen van Besien
Cytotherapy|March 21, 2015
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cellsCaroline A Lindemans, Koen van Besien
Leukemia & Lymphoma|September 14, 2020
Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?Ok-Kyong Chaekal, Koen van Besien
Leukemia & Lymphoma|November 25, 2021
Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!Alexandra Gomez-Arteaga, Koen van Besien
Pageof 25